Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models

Mammalian Target of Rapamycin complex 2 (mTORC2) and its regulatory component Rapamycin-insensitive companion of mTOR (RICTOR) are increasingly recognized as important players in human cancer development and progression. However, the role of RICTOR in human pancreatic ductal adenocarcinoma (PDAC) is...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Schmidt, Katharina M., Hellerbrand, Claus, Ruemmele, Petra, Michalski, Christoph W., Kong, Bo, Kroemer, Alexander, Hackl, Christina, Schlitt, Hans J., Geissler, Edward K., Lang, Sven A.
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2017
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5421865/
https://ncbi.nlm.nih.gov/pubmed/28445935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15524
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍